UnitedHealth, Elevance Health stocks drop toward four-day losing streaks in wake of earnings reports
Shares of UnitedHealth Group Inc. (UNH) sank 4.1% in afternoon trading Wednesday, which puts them on track to suffer the worst four-day performance -- down 8.1% -- in 15 months, after the health insurer's first-quarter earnings report raised concerns over the "unintended consequences" of changes to Medicare Advantage rates. Meanwhile, shares of Elevance Health Inc. (ELV) dropped 5.7%, and have slumped 8.2% amid a four-day losing streak, after the health care services company reported first-quarter earnings that beat expectations, but Mizuho analyst Ann Hynes said she believes the stock is under pressure as days claims payable (DCP) declined from the sequential fourth quarter and from a year ago. Among other health care services companies, shares of Centene Corp. (CNC) slid 3.7%, Humana Inc. (HUM) gave up 4.0% and Molina Healthcare Inc. (MOH) dropped 5.1%. The relatively big declines in health care services stocks contrasts with the S&P 500's rise of less than 0.1%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-19-23 1453ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters